TMCI
Treace Medical Concepts Inc
NASDAQ: TMCI · HEALTHCARE · MEDICAL DEVICES
$1.81
+1.69% today
Updated 2026-04-30
Market cap
$123.74M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$1 – $8
Volume
0.9M
Treace Medical Concepts Inc (TMCI) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-27.70%
Operating margin
-9.47%
ROE
-58.90%
ROA
-16.60%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $39.42M | $-4.26M | 80.64% | -8.97% | -10.82% |
| 2020 | $57.37M | $-3.67M | 78.26% | 1.49% | -6.39% |
| 2021 | $94.42M | $-20.55M | 82.11% | -17.49% | -21.77% |
| 2022 | $141.84M | $-42.81M | 80.60% | -24.57% | -30.19% |
| 2023 | $187.12M | $-49.53M | 81.20% | -27.48% | -26.47% |
| 2024 | $209.36M | $-55.74M | 80.37% | -26.60% | -26.63% |
| 2025 | $212.69M | $-59.00M | 79.81% | -25.46% | -27.74% |